Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1776 of 6351
-
Cash and texts: a new way to help older smokers kick the habit?
Disease control OngoingThis study aims to assess the effect of mobile health (mHealth) support or financial incentives and their interactive intervention effect on smoking cessation (SC) in old smokers in Hong Kong (HK).
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple wipe slash hospital infections?
Disease control CompletedThe aim of this randomized controlled trial is to verify whether the efficacy of perineal hygiene procedures performed in dependent patients admitted to medical or geriatric wards with pre-moistened wipes without water is higher than that found after procedures performed with dis…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a neck device curb opioid withdrawal?
Symptom relief Recruiting nowThis study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with a history of Opioid Use Disorders (OUDs)? Eligible participants will be in the study for one week in an inpatient researc…
Phase 3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Tailored brain zaps could help Parkinson's patients walk better
Symptom relief Recruiting nowThe objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each patient with Parkinson's disease, compared to conventional high-frequency rTMS therapy on bilateral primary…
Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New hope for rare tumor patients: chemo delivered directly to desmoid growths
Disease control Recruiting nowDesmoid fibromatoses are rare (1-2 cases/million per year) and locally aggressive mesenchymal tumors. For asymptomatic disease, current guidelines suggest an initial period of active surveillance. The current scientific evidence regarding the efficacy and safety of the treatment…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug aims to cut dangerous lung Flare-Ups in bronchiectasis patients
Disease control CompletedACT18018 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 study with 3 treatment groups. The purpose of this study is to evaluate efficacy, safety and tolerability with 2 dosing regimens of itepekimab compared with placebo in male and/or f…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Ultrasound zaps lung nerves to ease heart failure symptoms
Disease control By invitation onlyThis early feasibility study is intended to characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension
Sponsor: Gradient Denervation Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Breathing gas after heart surgery may stop deadly lung infection
Prevention CompletedThe primary aim of this single-center, prospective, randomized, controlled, study is to test the hypothesis that inhalation of NO 200 ppm prevents the development of nosocomial pneumonia in patients at risk after cardiac surgery under CPB. The study is interventional. Examination…
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
New Two-Drug combo targets Hard-to-Treat myeloma in early trial
Disease control Recruiting nowThe main purpose of the study is to understand how safe and tolerable is elranatamab when given along with iberdomide. There are 2 parts to this study. Part 1 will look at how safe and tolerable is elranatamab when given with iberdomide. Part 2 will look at the correct amount of…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for rare heart disease: experimental drug tested for long-term safety
Disease control OngoingThis study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe this medicine is in the long term and if it can reduce symptoms of a heart disease due to TTR amyloidosis, such as heart failure. It is an extension…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a 12-Month break from prostate cancer drugs be enough?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the outcomes of a shorter treatment duration (12 months) with an androgen receptor pathway inhibitor (ARPI), in this study Apalutamide or Enzalutamide, in patients with low-volume, hormone-sensitive metastatic prostate cancer (mCSPC)…
Phase 3 • Sponsor: Nick Beije • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
One hands-on session may reset a misbehaving pelvic joint
Disease control Completed* Summary Sacroiliac joint dysfunction (ASI) is an alteration in the normal biomechanics of the joint, which leads to hypomobility or hypermobility of that joint. It is one of the most common causes of misdiagnosis in low back pain and when not treated correctly, it often evolves…
Sponsor: Aveiro University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Poop pills may help lymphoma patients tolerate powerful cancer treatment
Disease control Recruiting nowTo find out if adding treatment with fecal microbiota transplantation (FMT) is effective at treating gut-related side effects of antibiotic treatment in participants who are receiving standard therapy with anti-CD19 chimeric antigen receptor T-cell (CAR-T cell) therapy.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New heart device aims to cut stroke risk in AFib patients
Disease control PausedThe purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked bl…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can intensive day therapy help teens beat anorexia?
Disease control Recruiting nowDuring the management of chronic illnesses, the day hospital (DH) serves as a brief and effective alternative to traditional hospitalization, offering access to multidisciplinary care. Indeed, patients can benefit from a range of therapeutic tools provided by a multidisciplinary …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Engineered immune cells aim to tame chronic GVHD
Disease control PausedThis phase I trial tests the safety, side effects, and best dose of allogeneic CD6 chimeric antigen receptor T regulatory cells (CD6-CAR Tregs) in treating patients who have chronic graft versus host disease (cGVHD) after an allogeneic hematopoietic cell transplantation (HCT). An…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New antibiotic could shield blood cancer patients from deadly infections
Disease control Recruiting nowAntibacterial prophylaxis is recommended in patients at high risk of infection, specifically patients undergoing acute leukemia induction therapy or hematopoietic stem cell transplant (HSCT) who are expected to have profound neutropenia (ANC\<100 neutrophils/milliliter) for more …
Phase 2 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug cocktail aims to shrink Hard-to-Treat throat cancer
Disease control PausedThis phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of improvement) (recurrent), has spread from where it first started (primary site) to ot…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a new suction technique help comatose patients breathe easier?
Symptom relief Recruiting now600 comatose patients admitted to the hospital in China from June 2024 to June 2028 were randomly divided into groups A and B. Group A used intermittent negative pressure suction through oral and pharyngeal ventilation, while group B used continuous negative pressure suction thro…
Sponsor: Affiliated Hospital of Nantong University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New drug aims to kickstart kidneys after transplant
Disease control OngoingThe main purpose of this study is to evaluate the safety, efficacy and tolerability of ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function. The study consists of 2 parts: part A comprises the main study period, and part B comprises the long…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC